Table 9.
Percentage antibiotic susceptibility of emerging microorganisms isolated in semen and glans exudate samples *.
| Agent | Susceptibility (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
A. schaalii (n = 3) |
A. sanguinis (n = 2) |
A. urinae, A. sanguinicola (n = 4) |
A. omnicolens (n = 1) |
C. glucuronolyticum (n = 13) |
F. hominis (n = 3) |
L. iners (n = 1) |
S. group bovis (n = 3) |
||
| Pen | P | 100 | 100 | 100 | 0 | 54 | 100 | ||
| AMP | 100 | 100 | 100 | 100 | 67 | ||||
| AMC | 100 | 100 | |||||||
| Cef | CTX | 100 | 100 | 100 | |||||
| Carba | IMP | 100 | 100 | 100 | 100 | ||||
| MEM | 100 | ||||||||
| Quino | CIP | 100 | 23 | 100 | |||||
| LEV | 100 | 100 | 33 | ||||||
| MXF | 100 | 0 | |||||||
| Amg | CN | 0 | |||||||
| Gcp | VA | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Tetrac | TE | 100 | 100 | 100 | 46 | 100 | 0 | ||
| Mcr | E | 77 | 100 | 0 | |||||
| AZM | 0 | ||||||||
| Linco | DA | 100 | 100 | 23 | 67 | ||||
| Oxa | LZD | 100 | 100 | 100 | |||||
| Ntm | MTZ | 0 | 0 | 0 | |||||
| Rif | RD | 100 | 100 | ||||||
| Sulf | SXT | 0 | 100 | ||||||
| FOS | 0 | 100 | |||||||
| F | 100 | ||||||||
* Antibiogram was not performed for C. amycolatum (n = 2), G. vaginalis (n = 11), or S. viridans group (S. anginosus) (n = 1). Penicillins (Pen), Cephalosporins (Cef, Carbapenems (Carba), Quinolones (Quino), Aminoglycosides (Amg), Glycopeptides (Gcp), Tetracycline (Tetra), Macrolides (Mcr), Lincosamides (Linco), Oxazolidone (Oxa), Nitroimidazole (Ntm), Rifampicin (Rif), Sulfamides (Sulf), Amoxicillin-Clavulanic (AMC), Ampicillin (AMP), Penicillin (P), Cefotaxime (CTX), Imipenem (IPM), Meropenem (MEM), Ciprofloxacin (CIP), Levofloxacin (LEV), Moxifloxacin (MXF), Gentamicin (CN), Vancomycin (VA), Tetracycline (TE), Erythromycin (E), Azithromycin (AZM), Clindamycin (DA), Linezolid (LZD), Metronidazole (MTZ), Rifampicin (RD), Trimethoprim-Sulfamethoxazole (SXT), Daptomycin (DAP), Fosfomycin (FOS), Nitrofurantoin (F).